{"schema_version":"1","generated_at":"2026-10-31T20:50:03.194Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nathan-denlinger","json_url":"https://www.findmykol.com/kol/nathan-denlinger/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nathan-denlinger","name":"Nathan Denlinger","credential":"DO","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"The Ohio State University Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/the-ohio-state-university","city":"Columbus","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1427444611","orcid":"0000-0002-7936-7547","openalex":"A5071795819"},"summary":"Nathan Denlinger is a Hematology physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 115 publications with 961 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":115,"cited_by_count":961,"h_index":15,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07676877","title":"Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma","phase":"PHASE1","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"Nathan Denlinger","source_url":"https://clinicaltrials.gov/study/NCT07676877","trial_url":"https://www.findmykol.com/trial/NCT07676877"},{"nct":"NCT06209619","title":"CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Nathan Denlinger","source_url":"https://clinicaltrials.gov/study/NCT06209619","trial_url":"https://www.findmykol.com/trial/NCT06209619"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":8,"shown":3,"withheld":5,"rows":[{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":8036.86,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427444611"},{"payer":"Cardinal Health 110 LLC","program_year":2025,"amount_usd":275,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427444611"},{"payer":"Incyte Corporation","program_year":2025,"amount_usd":125,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427444611"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1427444611","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2026,"journal":"Kidney International","source_url":"https://doi.org/10.1016/j.kint.2026.02.029","status":"verified"},{"title":"Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies","year":2025,"journal":"Journal of Hematology & Oncology","source_url":"https://doi.org/10.1186/s13045-025-01676-4","status":"verified"},{"title":"Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025015855","status":"verified"},{"title":"Isolated oral CD30+/CD4+ CAR+ T cell lymphoma in long-term remission after radiotherapy","year":2025,"journal":"Molecular Therapy","source_url":"https://doi.org/10.1016/j.ymthe.2025.08.043","status":"verified"},{"title":"Acute kidney injury after chimeric antigen receptor T‐cell therapy is associated with inferior survival in patients with relapsed/refractory large B‐cell lymphoma","year":2025,"journal":"British Journal of Haematology","source_url":"https://doi.org/10.1111/bjh.20240","status":"verified"}],"source":"works"},"contact":{"address_1":"460 W 10TH AVE","city":"Columbus","state":"OH","zip":"432101240","phone":"614-293-3196","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1427444611","source":"identity"},"similar":[{"name":"Gregory Otterson","slug":"gregory-otterson","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gregory-otterson","json_url":"https://www.findmykol.com/kol/gregory-otterson/profile.json"},{"name":"Raphael Pollock","slug":"raphael-pollock","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/raphael-pollock","json_url":"https://www.findmykol.com/kol/raphael-pollock/profile.json"},{"name":"Steven Clinton","slug":"steven-clinton","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/steven-clinton","json_url":"https://www.findmykol.com/kol/steven-clinton/profile.json"},{"name":"Claire Verschraegen","slug":"claire-verschraegen","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/claire-verschraegen","json_url":"https://www.findmykol.com/kol/claire-verschraegen/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":5,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-05-28","provider_certified":"2026-05-28","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}